Vector Immunogenicity
Vector immunogenicity is the inherent capacity of a gene therapy vector to provoke an immune response in the host organism, distinguishing it from other vector properties by its specific role in activating innate and adaptive immune pathways against the delivered genetic construct.
195
Publications
13.4K
Citations
1.6K
Authors
428
Institutions
Publications per year
2017–2026
44
195
Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization
Yukio Sato, Mark Roman, Helen Tighe et al. · Science · 1996 · 1.1K citations
Danilo R. Casimiro, Ling Chen, Tong‐Ming Fu et al. · Journal of Virology · 2003 · 398 citations · Full text
Gerd Sutter, Linda S. Wyatt, Patricia L. Foley et al. · Vaccine · 1994 · 291 citations
1–5 of 195
1.6K
6
h-index
5
h-index
National Institute of Allergy and Infectious Diseases, United States
5 publications · 726 citations
5
h-index
5
h-index
5
h-index
1–5 of 1.6K
428
National Institutes of Health
Bethesda, United States
16 h-index
64 publications
4.6K citations
University of Pennsylvania
Philadelphia, United States
15 h-index
60 publications
4K citations
National Institute of Allergy and Infectious Diseases
Bethesda, United States
13 h-index
57 publications
4.8K citations
Harvard University
Cambridge, United States
10 h-index
59 publications
9.4K citations

Beth Israel Deaconess Medical Center
Boston, United States
8 h-index
63 publications
6.1K citations

Thomas Jefferson University
Philadelphia, United States
7 h-index
25 publications
650 citations
Fred Hutch Cancer Center
Seattle, United States
7 h-index
29 publications
1.7K citations
Duke Medical Center
Durham, United States
7 h-index
22 publications
785 citations
1–8 of 428
JVI · 24 publications · 2.5K citations
22
h-index
14 publications · 972 citations
14
h-index
15 publications · 789 citations
14
h-index
11 publications · 830 citations
10
h-index
10 publications · 928 citations
10
h-index
1–5